The TSLC1 tumor-suppressor gene is silenced in a number of human cancer tissues and cell lines, including lung, prostate, liver, stomach, pancreatic, and breast cancers. Expression of TSLC1 in a non-small-cell lung cancer (NSCLC) cell line A549 suppresses tumorigenicity in nude mice. However, the molecular mechanism of TSLC1 action is not yet elucidated. In the present study, we show that the expression of TSLC1 from a recombinant adenovirus vector (Ad-TSLC1) inhibited cell proliferation and induced apoptosis in the NSCLC cell line A549. We also demonstrated that subcutaneous tumor growth in nude mice induced by A549 cells was suppressed to the extent of 70-80% by intratumoral injection of Ad-TSLC1. Re-expression of TSLC1 also resulted in activation of the apoptotic protease caspase-3, accompanied by the cleavage of its substrate poly (ADP-ribose) polymerase (PARP). The antiproliferative and proapoptotic activity of TSLC1 required the presence of the FERM-binding and PDZ-interacting motifs located in the cytoplasmic domain. Our results demonstrate the proapoptotic and oncosuppressive activity of TSLC1 protein, and suggest the potential of TSLC1 for gene therapy.
Introduction
The expression of the tumor-suppressor gene TSLC1 is abrogated or markedly reduced in a diverse number of human cancers, including lung cancer (Murakami et al., 1998; Kuramochi et al., 2001; Fukami et al., 2003) , prostate cancer , pancreatic cancer (Honda et al., 2002) , gastric cancer (Jansen et al., 2002) , and breast cancer (Allinen et al., 2002) . Reexpression of TSLC1 in non-small-cell lung cancer (NSCLC) cells or in prostate cancer cells suppressed tumorigenicity in nude mice (Kuramochi et al., 2001; Fukuhara et al., 2002) . The TSLC1 protein is a transmembrane glycoprotein of 442 amino acids, consisting of an extracellular domain containing three immunoglobulin-like C2 domains, a transmembrane domain and a cytoplasmic domain (Kuramochi et al., 2001 ). The extracellular domain shows very high homology with those of other Ig superfamily cell adhesion molecules (Ig-CAM), particularly with the neural cell adhesion molecules N-CAM1 and N-CAM2 (Kuramochi et al., 2001; Masuda et al., 2002) . Similar to the Ig-CAM proteins, TSLC1 also mediates intracellular cell-cell adhesion . The cytoplasmic domain harbors two protein-protein interaction motifs, a protein 4.1/ezrin/radixin/moesin (FERM)-binding motif and a PDZ-interacting motif. Recently, we have shown that both of these motifs play critical roles in the tumor-suppressor activity of TSLC1 (Mao et al., 2003) . A direct association between TSLC1 and another tumor-suppressor protein containing a FERMdomain, DAL-1, has been established, suggesting that DAL-1 interacts with TSLC1 through the FERMbinding motif of TSLC1 . TSLC1 has also recently been shown to directly interact with MPP3, one of the members of the membrane-associated guanylate kinase (MAGUK), through its PDZ-interacting motif . However, the molecular mechanism(s) of tumor suppression by TSLC1 has not yet been elucidated.
A number of tumor suppressors function by inducing apoptosis, and loss of the tumor-suppressor gene function was shown to reduce apoptotic activity and increase tumor growth (Ji et al., 1999; Roz et al., 2002; Saeki et al., 2002) . Thus, restoration of expression of tumor-suppressor genes in human cancer cell lines in which the expression of the tumor-suppressor genes are abrogated or reduced leads to induction of apoptosis and inhibition of tumor growth (Ji et al., 1999; Saeki et al., 2000 Saeki et al., , 2002 Roz et al., 2002) . In an effort to elucidate the molecular mechanism of action of TSLC1 in tumor suppression, we restored the expression of TSLC1 in a NSCLC cell line, A549, using recombinant adenoviral vector-mediated gene transfer. Here we demonstrate that re-expression of TSLC1 in A549 resulted in marked increase in apoptosis and impaired cell proliferation. In addition, intratumoral injection of recombinant adenoviral vector containing wild-type TSLC1 gene markedly suppressed the growth of human NSCLC xenografts in nude mice.
Results

Adenovirus-vector transduced expression of TSLC1 in lung cancer cells
The NSCLC cell line A549 expresses a very low level of TSLC1 protein and induces tumors in nude mice (Murakami et al., 1998; Kuramochi et al., 2001) . Previously, we established A549 cells stably expressing TSLC1 protein at a level similar to normal human lung tissues. These A549 cells stably expressing TSLC1 failed to induce subcutaneous tumor in nude mice, indicating that TSLC1 is a tumor suppressor (Kuramochi et al., 2001; Mao et al., 2003) . In an effort to obtain efficient gene transfer and high level of gene expression, we used an adenoviral vector system to study the effect of overexpression of TSLC1 in A549 cells on cell proliferation, apoptosis, and in vivo tumor growth. Results of immunoblot analyses presented in Figure 1 show that A549 cells infected with Ad-TSLC1 virus express TSLC1 protein while cells infected with control adenovirus lacking any insert failed to express any TSLC1 protein. The level of the protein expressed depends on the MOI used as well as the length of infection. In agreement with our earlier reports (Kuramochi et al., 2001; Mao et al., 2003) , immunofluorescence analyses of the infected cells demonstrated the presence of TSLC1 protein in the cell surface. Quantitation of the surface fluorescence was used to measure the transduction efficiency of the adenoviral vector system. The transduction efficiency of the recombinant adenoviruses was about 80-90% at the high MOIs used in this study.
Expression of TSLC1 inhibits cell proliferation
Previously, we showed that A549 cells stably expressing TSLC1 protein showed a decreased ability for anchorage-independent growth in soft agar (Mao et al., 2003) . To test if expression of TSLC1 inhibits cell proliferation, we used the MTT assay to determine the number of viable cells at 3 and 5 days after transduction with adenoviruses at various MOIs. The viability of transduced cells was compared with that of untransduced PBS-treated control cells. The results presented in Figure 2 show that cell viability was markedly reduced for TSLC1-transduced A549 cells. Thus, after 5 days of transduction at 50 MOI, cell viability was reduced by about 80%. In contrast, the growth of cells treated with control virus containing no inserts, Ad-BHG, was only slightly affected.
Expression of TSLC1 induces apoptosis
Apoptotic cell death in A549 cells transduced by Ad-TSLC1 was determined by staining A549 cells with the DNA-intercalating dye Hoechst 33342 and then examining the cells under a fluorescence microscope. The results presented in Figure 3 show that tumor cells transduced by Ad-TSLC1 but not by the control virus Ad-BHG underwent apoptotic cell death, as characterized by chromosomal condensation and partial fragmentation of nuclear DNA. The extent of apoptotic bodies was dependent on the MOI of Ad-TSLC1 and the length of infection. Quantitative analyses indicated after 3 days of infection about 15 and 30% of A549 cells infected with 20 and 50 moi, respectively, of Ad-TSLC1 showed apoptosis (Figure 3b ).
To investigate further the TSLC1-mediated death of tumor cells, A549 cells were infected with either Ad-TSLC1 or the control empty vector Ad-BHG and then stained with PI. Results of FACS analyses showed significant increase in the number of cells in the sub-G1 fraction (Figure 4) . Thus, 60% of cells transduced with Ad-TSLC1 were in the sub-G1 fraction after 5 days compared to only 18% of cells infected with the control Oncosuppressive and apoptotic activity of TSLC1 X Mao et al virus Ad-BHG being in the sub-G1 fraction, indicating that the suppression of cell proliferation by TSLC1 may be due to induction of apoptosis.
In an effort to rule out possible cell death due to necrosis, we analysed A549 cells expressing TSLC1 by TUNEL staining of the fragmented DNA as well as Annexin V assay measuring alterations in the plasma membranes of apoptotic cells. Results presented in Figure 5 show that TUNEL-positive A549 cells are also expressing TSLC1. While cells infected with the control Ad-BHG fail to show expression of TSLC1 and the presence of TUNEL-positive cells. Ad-TSLC1 infection also resulted in an increase in Annexin V-positive cells indicating early apoptotic change; in contrast, infection with Ad-BHG showed no Annexin V staining ( Figure 6 ).
Since expression of TSLC1 resulted in reduced cell proliferation and increased apoptosis, the activation of caspase cascade involved in apoptosis was further studied. In most apoptotic cells, caspase-3, an effector caspase, is activated by cleavage of the pro-caspase-3 molecule. Caspase-3 activity was measured using spectrophotometric detection of the cleavage of p-nitroanilide from a labeled substrate specific for caspase-3. Caspase-3 activity was increased by 2-4-fold due to expression of TSLC1 ( Figure 7a 
Suppression of tumor growth by intratumoral injection of Ad-TSLC1
We have previously shown that stable expression of TSLC1 in A549 cells suppressed its tumorigenic potential in nude mice (Kuramochi et al., 2001; Mao et al., 2003) . We, therefore, examined the tumorigenic activity of A549 cells transduced with Ad-TSLC1 or Ad-BHG. As expected, tumor cells expressing TSLC1 abrogated tumorigenic activity in nude mice, while A549 cells transduced with Ad-BHG formed tumors similar to its parent cell line (data not presented). We next evaluated the efficacy of TSLC1 in suppressing tumor growth in vivo by direct injection of Ad-TSLC1 into tumors formed by A549 cells in nude mice. The high efficiency of transduction and high level of expression of TSLC1 by the adenovirus-vector system allowed intratumoral injection when the tumor grew to an average volume of about 50 mm 3 . The growth of tumors was recorded from the first injection until 21 days after the last injection ( Figure 8 ). Tumors treated with Ad-TSLC1 showed significantly suppressed growth compared with tumors injected with control virus Ad-BHG or with PBS. Thus, in the cases of Ad-BHG-and PBS-injected tumors, the average tumor size increased from 53 to 317 mm 3 and 49 to 308 mm 3 , respectively, within 24 days after virus injection. In contrast, the average tumor size injected with Ad-TSLC1 increased from 52 to 116 mm 3 during the same period. Thus, within 24 days, there is an increase of 264 or 259 mm 3 in tumor size in tumors injected with Ad-BHG or PBS, while an increase of 64 mm 3 was observed in Ad-TSLC1-injected tumors, indicating a suppression of about 70% in the growth of the tumor.
Protein-protein interacting motifs in the cytoplasmic domain of TSLC1 is critical for inhibition of cell proliferation and induction of apoptosis
We have earlier shown that two protein-protein interacting motifs, namely, the FERM-binding and the PDZ-interacting motifs present in the carboxy terminal domain, were critical for not only the tumor-suppressor activity of TSLC1, but also for cell-cell adhesion and anchorage-independent growth in soft agar (Mao et al., 2003) . To evaluate if these two protein-protein interacting motifs were critical for cell proliferation and apoptosis, we examined the abilities of TSCL1 mutants lacking the entire cytoplasmic tail (CT1), the FERMbinding motif (CT3) or the PDZ-interacting motif (CT4) for inhibition of cell growth and induction of apoptosis. The mutants CT1, CT3, or CT4 were cloned into the recombinant adenoviral vector, and transduction of A549 cells with Ad-CT1, Ad-CT3 or Ad-CT4 resulted in a high level of expression of the mutant TSLC1 proteins (data not shown). The results presented in Figure 9 showed that cells expressing the three mutant TSLC1 Oncosuppressive and apoptotic activity of TSLC1 X Mao et al protein-protein interaction motifs are critical not only for tumor-suppressor activity but also for proliferation and apoptosis of tumor cells.
Discussion
Loss or reduction in the expression of the tumorsuppressor gene TSLC1 was shown to be involved in the development and metastasis of multiple forms of tumors in human (Kuramochi et al., 2001; Fukami et al., 2003; Ito et al., 2003; Uchino et al., 2003) . Although TSLC1 is suggested to be involved in cell-cell adhesion and cell motility Yageta et al., 2002; Fujita et al., 2003) , its mechanism of action in suppression of tumor growth and metastasis is not known. Our studies presented here demonstrate for the first time that TSLC1 can induce apoptosis in NSCLC. Using a recombinant adenovirus vector system, we show that expression of TSLC1 in A549 cells not only inhibited the tumor cell growth and proliferation both in vitro and in vivo, but also induced apoptosis. Toxicity of the viral vector was ruled out because the control empty virus vector AdBHG did not cause inhibition of cell growth or induction of apoptotic cell death. Ad-TSLC1-infected A549 cells showed increased degradation of nuclear DNA and alteration of the plasma membrane specific for apoptotic cells and increase in sub-G1 population of cells. Increase in level of the critical apoptosis-related enzymes, caspase-3, and cleavage of its substrate, PARP, was also observed. Similar increases in apoptosis and sub-G1 cell population, as well as activation of the executor caspase 3 and the cleavage of caspase substrate PARP, was also reported as a result of adenovirusmediated expression of a number of tumor suppressors, such as melanoma differentiation-associated gene 7 (mda-7), fragile histidine triad (FHIT) or p16 (Ji et al., 1999; Saeki et al., 2000 Saeki et al., , 2002 Katsuda et al., 2002; Roz et al., 2002) . Activation of caspase-3 and cleavage of the caspase substrate PARP indicated activation of the caspase cascade (Ashe and Berry, 2003) . However, details of the apoptotic pathways induced by TSLC1 as well as the molecular mechanism(s) involved are currently unknown. The intracellular domain of TSLC1 contains two major protein-protein interaction motifs that are involved in linkage of membrane proteins to the cytoskeletal structure, assembly of multiprotein complexes, signal transduction, and subcellular targeting of proteins (Hoover and Bryant, 2000; Harris and Lim, 2001; Kuramochi et al., 2001; Sheng and Sala, 2001 ). The roles played by the two domains in suppression of tumorigenicity and metastasis are not yet elucidated. We have previously demonstrated the critical role of FERM-binding and PDZ-interacting motifs in tumorigenicity, cell-cell adhesion, and cell growth (Mao et al., 2003) . Here, we further demonstrate the importance of these motifs in cell proliferation, and apoptotic cell death. Studies from Murakami's group have identified the binding partners of these two motifs Fukuhara et al., 2003) . The FERM-binding motif 3 in size, Ad-TSLC1 or Ad-BHG viruses were administrated intratumorally at a total dosage of 3 Â 10 10 pfu/tumor, as described in Materials and methods. The tumor sizes were measured every 2 or 3 days. The experiment was terminated on the 24th day after the first injection of adenovirus. Tumors were also injected intratumorally with PBS as a control. Shown here is the tumor growth curve after intratumoral administration of Ad-TSLC1, Ad-BHG or PBS. The data presented here are representative of two separate experiments
Oncosuppressive and apoptotic activity of TSLC1 X Mao et al of TSLC1 associates with DAL-1, another lung cancer tumor suppressor that can link to cytoskeletal actin filaments (Tran et al., 1999; Yageta et al., 2002) . The PDZ-interacting motif was shown to interact with MPP3 (DLG3), one of the human homologues of a Drosophila tumor suppressor Dlg (Smith et al., 1996; Fukuhara et al., 2003) . Amino-acid sequence identity and similarity of the domain structure of MPP3 to those Oncosuppressive and apoptotic activity of TSLC1 X Mao et al of p55 (MPP1), which is the prototypic member of a subfamily of MAGUK proteins, also indicate that MPP3 belongs to this subfamily (Smith et al., 1996) . MAGUK proteins are found to be localized in the membrane-cytoskeletal interface, particularly at the cell-cell junctions. The reported co-localization of TSLC1 and MPP3 at the cell-cell attachment site suggests that both of them may be involved in cell-cell adhesion. Thus, TSLC1 may send signals through MPP3, which are transmitted via downstream proteins to inhibit cell proliferation and to induce apoptotic cell death. A ternary complex of TSLC1, MPP3, and DAL-1 may also be formed at the cell-cell attachment site and may play a critical role in cell proliferation, cell-cell adhesion, induction of apoptotic cascades, and suppression of tumorigenesis. Human glycophorin C contains a FERM-binding and a PDZ-binding motif that are 85 and 100% identical, respectively, to the corresponding motifs present in TSLC1, was shown to form a ternary complex with erythrocyte 4.1 protein, a prototypic member of FERM-domain family of proteins and p55 (MPP1). The 4.1 protein links glycophorin C to the cytoskeleton via its actin-spectrin-binding domain. The p55 protein also interacted with the 4.1 protein via its FERM-binding motif, leading to the formation of a ternary complex containing glycophorin C, which is critical for membrane-cytoskeletal interaction and the shape and function of erythrocytes (Marfatia et al., 1995 (Marfatia et al., , 1997 ).
Although we cannot establish a molecular mechanism(s) of TSLC1 tumor suppressor activity, the activation of the effector capase-3 and cleavage of PARP protein induced by TSLC1 suggests the involvement of apoptotic signaling cascades (Katsuda et al., 2002; Ashe and Berry, 2003) . The fact that both the FERM-binding and the PDZ-interacting motifs are essential for apoptotic tumor cell death induced by TSLC1 further suggests that a multi-protein complex containing TSLC1, DAL-1, MPP-1, and possibly other interacting proteins, plays a critical role modulating the signaling pathway(s) involved in the organization of cytoskeleton scaffolding, cell-cell adhesion, cell proliferation, and apoptosis. In addition, the Rho family of small GTPases are known to mediate cytoskeletal response to cell signaling as well as to play a role in apoptosis, suggesting that this family of GTPases may be involved in the biological function of TSLC1 (Hall, 1998; Aznar and Lacal, 2001) .
Finally, this study demonstrated for the first time the antitumor activity of TSLC1 in lung tumor xenografts in vivo by intratumoral injection of Ad-TSLC virus. The proapoptotic and the oncosuppressive activities of TSLC1, thus, suggest the future possibility of its use in gene therapy against lung cancer.
Materials and methods
Cell culture
The A549 lung cancer cell line was maintained in D-MEM medium, containing 10% fetal bovine serum (FBS). HEK 293 cell line, used for construction, amplification, and titration of adenoviral vectors, was maintained in D-MEM containing 4.5 g/l glucose and 10% FBS.
Chemicals and antibodies
Propidium iodide, MTT, and Hoechst 33342 were purchased from Sigma. Anti-PARP polyclonal antibody was purchased from NEB Labs. Monoclonal anti-b-actin (ICN, Aurora, OH), anti-caspase-3 antibodies, and anti-mouse IgG secondary antibody were generous gifts from Dr David W Andrews. Anti-rabbit IgG secondary antibodies were purchased from Jackson ImmunoResearch Laboratory Inc. (West Grove, PA, USA). Anti-EC and anti-CT antibodies against TSLC1 were generated as reported previously (Mao et al., 2003) .
Construction of recombinant adenoviruses
Wild-type TSLC1 cDNA was cloned into the shuttle plasmid pDC315 between the EcoRI and SalI cloning sites. The sequenced and purified pDC315-TSLC1 plasmid and the Ad genomic plasmid pBHG lox (delta) E1, E3 Cre were cotransfected into 293 cells for site-specific Cre-mediated recombination (Ng and Graham, 2002) . The control Ad-BHG is E1-and E3-deleted, but has no transgene insertion. The recombinant adenovirus Ad-TSLC1 was used after purification, characterization, and titration of the viral infectivity by plaque assay.
Western blotting assay
Expression of the TSLC1 protein was analysed by Western blotting. Cells grown to 50% confluence in 60-mm dishes were infected with Ad-TSLC1 at MOIs of 10, 20, or 50 pfu/cell. The Ad-BHG-DE1E3 (Ad-BHG) lacking any insert was used as an empty virus control. After 3 or 5 days, cells were harvested to prepare cell lysates as previously reported (Mao et al., 2003) . In all, 5 mg of total protein from each cell lysate was subjected to SDS-PAGE. The protein blots were treated with appropriate polyclonal or monoclonal antibodies. The detection kit, Western LightningTM Chemiluminescence Reagent Plus (Perkin-Elmer Life Sciences, Inc., Boston, MA, USA), was used for visualization of the immunocomplexes. For reprobing the blots, the membrane was stripped as instructed by the manufacturer. The membrane was then used for probing with the next antibody. An anti-b-actin blot was made in parallel as a loading control.
Cell proliferation assay
A549 cells grown on 12-well plates to about 50% confluency were infected with Ad-TSLC1 or Ad-BHG viruses at MOIs of 10, 20 or 50 pfu/cell. The cell numbers were determined by MTT assay after 3 or 5 days of infection (Ji et al., 1999; Saeki et al., 2002) . Briefly, cells were incubated with 0.5 mg/ml of MTT for 2-4 h at 371C. After the removal of the solution, the purple precipitates were dissolved in DMSO for 20 min at room temperature and the resultant solution was transferred to 96-well plates, and the absorbance was measured at 570 nm using a multi-well plate reader. The experiment was repeated three times.
Apoptotic cell staining by Hoechst dye A549 cells were grown on 22 Â 22 mm coverslips overnight before being infected with Ad-TSLC1 virus at an MOI of 5, 10, 20 or 50 pfu/cell or with Ad-BHG virus at an MOI of 20 or 50 pfu/cell. After infection of 3 or 5 days, the cells were incubated for 15 min at 371C with 100 mg/ml of Hoechst 33342 dye, washed with PBS and observed under a fluorescence microscope with a UV filter (Saeki et al., 2002) . The apoptotic cells were counted and photographed. A total of 20 fields per group was counted and the results were represented as the average number of apoptotic cells per field.
Apoptosis and cell cycle analyses
A549 cells were infected with Ad-TSLC1 virus at an MOI of 10, 20 or 50 pfu/cell or with Ad-BHG virus at an MOI of 50 pfu/cell. After incubation for 3 or 5 days, cells were harvested and single-cell suspensions were prepared by passing the cells through a nylon mesh. The single cells then were fixed with 70% ethanol at À201C for 2 h. The fixed cells were washed three times with cold PBS and suspended in staining buffer (0.1% Triton X-100, 3.8 mM sodium citrate in PBS) and adjusted to a cell density of 1-2 Â 10 6 cell/ml. The cells were than incubated with 5.0 mg/ml of propidium iodide and 10 mg/ ml of RNase A at room temperature for 30 min in the dark (Ji et al., 1999; Roz et al., 2002; Saeki et al., 2002 ). The single cells were then subjected to FACScan analysis on a Beckman flow cytometer.
TUNEL assay
Apoptotic cells were detected by TUNEL assay using the Dead End fluorimetric TUNEL system kit from Promega (Madison, WI, USA) following the manufacturer's instruction. Briefly, cells were grown on coverslips and infected with Ad-TSLC1 or Ad-BHG viruses at the indicated MOIs. Cells were fixed with 2% paraformaldehyde and then permeabilized with 70% ethanol at 41C. Cells were then labeled with FITC-labeled dUTP using the TdT enzyme. Following TUNEL labeling, cells were stained for expressed TSLC1 using the anti-EC antibody and Rhodamine red X-labeled anti-rabbit IgG, and the nuclei by Hoechst 33342 dye. Apoptosis was quantified by counting the number of TSLC1-expressing cells that were TUNEL-positive. A total of at least 300 cells from six different fields were counted.
Annexin V assay
Apoptotic cells were also detected by using the Annexin V-FITC kit from Beckman Coulter (Toronto, Canada). Cells grown on coverslips were stained with Annexin V and propidium iodide following the manufacturer's instructions. Cells were then stained with Hoechst 33342 and analysed by fluorescence microscopy.
Fluorescence microscopy
All fluorescence microscopic images were captured on a Nikon TE200 or Zeiss Axiovert 200 epiflourescent inverted microscope equipped with a digital camera. Captured images were deconvolved using the Autodebluv v9.1 software (Autoquant Imaging, Albany, NY, USA).
Activation of caspase cascade
Activation of the apoptotic caspase cascade in A549 cells infected with Ad-TSLC1 was monitored by enzymatic assay of caspase 3 and Western blot analyses for cleavages of the caspase substrate PARP. A549 cells infected with Ad-TSLC1 or Ad-BHG for 3 or 5 days were lysed and the cell lysates were either immunoblotted using anti-PARP antibodies or assayed for hydrolysis of the caspase-3 substrate DVED-paranitroanilide using the colorimetric caspACE assay kit from Promega (Madison, WI, USA).
Suppression of tumor growth by intratumoral injection of Ad-TSLC1
To study the effect of TSLC1 on tumor growth, A549 cells were used to establish subcutaneous tumors in nude mice (Kuramochi et al., 2001; Mao et al., 2003) . Briefly, 2 Â 10 6 A549 cells were injected into the two flanks of 5-6-week-old female nude mice (BALB/c, nu/nu, Charles River, Cambridge, MA, USA). When the tumor volumes reached around 50 mm 3 at about 2 weeks postinjection, animals were randomly divided into three groups: eight for Ad-TSLC1 injection, four for Ad-BHG injection, and four for PBS injection. Adenoviruses were injected intratumorally into each tumor for four times at days 1, 3, 5, and 7, at a total dose of 3 Â 10 10 pfu/tumor (5 Â 10 9 pfu/ tumor for the first two injections and 1 Â 10 10 for the last two injections) (Ji et al., 1999) . Tumor size was measured and calculated by the formula V ¼ 0.5 Â L Â W Â H (L is for length, W for width, and H for height) (Kuramochi et al., 2001; Mao et al., 2003) . All animals were maintained and all experiments were carried out under institutional guidelines established for the Animal Facility Center at McMaster University.
Cytoplasmic mutants of TSLC1 in adenoviral vectors
The cytoplasmic domain mutants, TSLC1-CT1(DCT), TSLC1-CT3(DFERM) and TSLC1-CT4(DPDZ) (Mao et al., 2003) , were cloned into an adenoviral vector to generate Ad-CT1, Ad-CT3 and Ad-CT4 viruses, respectively (Ng and Graham, 2002) . These mutant viruses were infected into A549 cells used for cell proliferation, apoptosis, and PARP cleavage analyses as described above.
Statistics
Both the in vitro and the in vivo results were expressed as mean7s.d. Student's t-test was used to compare the values of the test and control samples. A value of Po0.05 was taken as significant.
